Navigation Links
Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/19/2008

2006.

2007 Achievements

-- Completed and reported positive results from Trial CL-07, a thorough

QT study for cethromycin which showed that cethromycin had no effect

on QT changes, supporting its favorable cardiac safety profile;

-- Completed private placement financing with existing and new

shareholders which added net proceeds of $18 million in cash to the

balance sheet;

-- Progressed negotiations with multiple prospective partners regarding

the commercial development of cethromycin as a treatment for CAP;

-- Completed clinical development and released positive efficacy and

safety data from two pivotal Phase III clinical trials that enrolled

over 1,100 patients from over 200 clinical sites worldwide for the use

of cethromycin to treat CAP;

-- Engaged an outside contract research organization to complete medical

writing activities and conversion of the NDA database into electronic

filing format;

-- Completed API and drug product manufacturing and initiated stability

testing to support the CMC requirements for the cethromycin NDA

submission;

-- Completed microbiology surveillance studies necessary for the

cethromycin NDA submission;

-- Completed efficacy study in which cethromycin was shown to be

100% protective in preventing inhalation anthrax in non-human

primates;

-- Granted Orphan Drug Designation by the FDA for the use of cethromycin

in the prophylactic treatment of patients exposed to inhalation

anthrax;

-- Presented 11 posters on cethromycin at The American Society for

Microbiology's 47th Annual Interscience Conference on Antimicrobial

Agents and Chemotherapy (ICAAC) in Chicago and the 45th Annual Meeting

of the Infectious Disease Society of America (IDSA) in San Diego;

-- Forme
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that ... County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is ... from and how agriculture impacts their daily lives. This unique exhibit also features a ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry ... market with a focus on the Chinese situation. Major companies included in the propanol ... Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides ...
(Date:7/30/2015)... --  Senomyx , Inc. (NASDAQ: SNMX ), a ... develop, and commercialize novel flavor ingredients for the food, ... for the second quarter 2015. "Moving ... track to achieve our commercial and financial goals," stated ... Company. "Since our last quarterly earnings report, our two ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... YORK, Jan. 16 With the field of ... the Society for Biological Engineering,(SBE) has organized the ... which runs from January 20th to 23rd at ... focus on,engineering designs for stem cell production, moving ...
... 1/11/08, SPOKANE, Wash., Jan. 16 On January ... of estriol in compounded hormone,replacement therapy. While awaiting further ... Cheryle Hart, M.D.,is Mayo Clinic trained and Board certified ... in 1997. She is also the medical director of ...
... Joins Company as Lead Product Progresses in Phase 2 ... ... VIA Pharmaceuticals,(Nasdaq: VIAP ), a biotechnology company focused on the development ... M.D. has joined VIA as senior vice president of research,and development. Dr. ...
Cached Biology Technology:Society for Biological Engineering Holds First International Conference on Stem Cell Engineering 2Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol 2VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 3VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 4
(Date:7/31/2015)... 2015 La 10e Conférence internationale sur ... par le BGI du 22 au 25 octobre ... Chine. La conférence célèbre son 10e ... l,ICG est devenue l,une des réunions annuelles mondiales ... et c,est aussi la plus dynamique, la plus ...
(Date:7/31/2015)... , July 31, 2015 The 10 th ... held by BGI from October 22-25, 2015, in Shenzhen ... The conference is celebrating its 10 th anniversary this year. ... the world,s most influential annual meetings in the ,omics, fields, ... scientific gatherings. ICG-10 focuses on recent breakthroughs ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... -- The mysterious disease that has killed more than ... mines from Vermont to Virginia during the last three ... the disease and how to control it. Leading ... ecotoxicology, disease and environmental modeling, among others, will gather ...
... This release is available in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/kcl-nss060209.php,">Chinese . ... devastating natural disaster across the globe. It is the ... of about 1.5 billion. The figure is expected to ... (Association of British Insurers). Floods that took place in ...
... have been elected to Fellowship in the American ... elected annually through a highly selective, peer-review process, ... original contributions that have advanced microbiology. There are ... microbiology, including basic and applied research, teaching, public ...
Cached Biology News:Scientists unravel the mystery of white-nose syndrome 2Scientists unravel the mystery of white-nose syndrome 3Next-generation software system for flood warning and risk analysis to be developed 2Seventy-three scientists elected to the American Academy of Microbiology 2Seventy-three scientists elected to the American Academy of Microbiology 3Seventy-three scientists elected to the American Academy of Microbiology 4
Mouse monoclonal antibody raised against a partial recombinant VEGFB. NCBI Entrez Gene ID = VEGFB...
... 200 series of microplate readers combines reagent ... in an affordable, easy-to-use platform for the ... unique modular design and adaptability of the ... choice of a monochromator (M200) or filter ...
...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
Biology Products: